Skip to content

Clinical trials

Autistic Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Country / region: Canada Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20112
20122
20132
20162
20172
20182
20192
20201
20224
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting5
Unknown status4
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Holland Bloorview Kids Rehabilitation Hospital8
Centre for Addiction and Mental Health2
Forest Laboratories2
MapLight Therapeutics2
Western University, Canada2
Children's Treatment Network1
Daniel Benjamin1
Daniel Coury1
Hamilton Health Sciences Corporation1
Jessica Brian1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder28
Autism Spectrum Disorder20
Anxiety Disorders3
Asperger Syndrome2
Attention Deficit Disorder with Hyperactivity2
Fragile X Syndrome2
Schizophrenia2
Social Communication Disorder2
22q11 Deletion Syndrome1
Adenoviridae Infections1

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.